About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDPhase 2/3NCT04775329

Primary Prophylaxis for Spontaneous Bacterial Peritonitis

Patient with liver cirrhosis commonly have co-existing small bowel bacterial overgrowth (SIBO) yet may be asymptomatic. It is unclear as to the value of treating SIBO in asymptomatic individuals. Cirr...

Lead sponsor: Changi General Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Changi General Hospital

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Decompensated liver cirrhosis (Childs B \& C) with ascites.
•Established diagnosis of SIBO

Exclusion Criteria

•Known allergy to treatment drugs
•Inability to undergo test confirm the success of SIBO eradication;
•Pregnant or lactating women
•Terminal malignancy.
•Untreated Viral Hepatitis
•Alcoholic Liver disease with ongoing drinking.
•Respiratory Failure
•Recent antibiotics and proton-pump inhibitor within 30 days

Related studies

Effect of Whey Protein Versus Egg Albumen Protein Challenge on Blood Ammonia Level in Patients of Decompensated Ethanol Related Cirrhosis.

NCT07299110 · Decompensated Cirrhosis Ethanol Related

Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis

NCT06855056 · Liver Cirrhosis, Decompensated Cirrhosis of Liver

Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival

NCT06431919 · Decompensated Cirrhosis, Cirrhotic Cardiomyopathy, and more

Enrolling By InvitationPhase 1/2

HCL001 Cell Injection for Decompensated Cirrhosis: A Phase I/II Trial

NCT07488546 · Decompensated Cirrhosis

TERMINATEDPhase 2

A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

NCT06987968 · Hepatic Encephalopathy, Acute on Chronic Liver Failure (ACLF), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 6, 2023Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2/PHASE3

Enrollment2

Start dateNov 2020

Last updatedJan 6, 2023

Condition

Decompensated Cirrhosis Small Bowel Bacterial Overgrowth Syndrome

Locations shown

Wong Yu Jun

Singapore

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 6, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions